Rational design of platinum(IV) compounds to overcome glutathione-S- transferase mediated drug resistance

Journal of the American Chemical Society

Volumn 127, Issue 5, 2005, Pages 1382-1383

  Wee, Han Ang ^a   Khalaila, Isam ^a   Allardyce, Claire S ^a   Juillerat Jeanneret, Lucienne ^b   Dyson, Paul J ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETACRYNIC ACID; ETHACRAPLATIN; GLUTATHIONE TRANSFERASE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG INHIBITION; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MULTIDRUG RESISTANCE;

CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; ETHACRYNIC ACID; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; ORGANOPLATINUM COMPOUNDS;

EID: 13444306285     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0432618     Document Type: Article

References (17)

1. Fuertes, M. A.; Alonso, C.; Perez, J. M. Chem. Rev. 2003, 103, 645-662.
2. Niitsu, Y.; Takahashi, Y.; Ban, N.; Takayama, T.; Saito, T.; Katahira, T.; Umetsu, Y.; Nakajima, T.; Ohi, M.; Kuga, T.; Sakamaki, S.; Matsunaga, T.; Hirayama, Y.; Kuroda, H.; Homma, H.; Kato, J.; Kogawa, K. Chem.-Biol. Interact. 1998, 112, 325-332.
3. Goto, S.; Iida, T.; Cho, S.; Oka, M.; Kohno, S.; Kondo, T. Free Radical Res. 1999, 31, 549-558.
4. Ferrandina, G.; Scambia, G.; Damia, G.; Tagliabue, G.; Fagotti, A.; Panici, P. B.; Mangioni, C.; Mancuso, S.; DIncalci, M. Ann. Oncol. 1997, 8, 343-350.
5. Nakajima, T.; Takayama, T.; Miyanishi, K.; Nobuoka, A.; Hayashi, T.; Abe, T.; Kato, J.; Sakon, K.; Naniwa, Y.; Tanabe, H.; Niitsu, Y. J. Pharmacol. Exp. Ther. 2003, 306, 861-869.
6. (a) Schultz, M.; Dutta, S.; Tew, K. D. Adv. Drug Delivery Rev. 1997, 26, 91-104.
7. (b) Morgan, A. S.; Ciaccio, P. J.; Tew, K. D.; Kauvar, L. N. Cancer Chemother. Pharmacol. 1996, 37, 363-370.
8. Takamatsu, Y.; Inaba, T. Toxicol. Lett. 1992, 62, 241-245.
9. Odwyer, P. J.; Lacreta, F.; Nash, S.; Tinsley, P. W.; Schilder, R.; Clapper, M. L.; Tew, K. D.; Panting, L.; Litwin, S.; Comis, R. L.; Ozols, R. F. Cancer Res. 1991, 51, 6059-6065.
10. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451-2466.
11. Galanski, M.; Keppler, B. Inorg. Chem. 1996, 35, 1709-1711.
12. Giandomenico, C. M.; Abrams, M. J.; Murrer, B. A.; Vollano, J. F.; Rheinheimer, M. I.; Wyer, S. B.; Bossard, G. E.; Higgins, J. D. Inorg. Chem. 1995, 34, 1015-1021.
13. Hall, M. D.; Hambley, T. W. Coord. Chem. Rev. 2002, 232, 49-67.
14. Tew, K. D. Cancer Res. 1994, 54, 4313-4320.
15. Dietze, E.; Grillo, M.; Kalhorn, T.; Nieslanik, B.; Jochheim, C.; Atkins, W. Biochemistry 1998, 37, 14948-14957.
16. Oakley, A. J.; Rossjohn, J.; Lo Bello, M.; Caccuri, A. M.; Federici, G.; Parker, M. W. Biochemistry 1997, 36, 576-585.
17. Townsend, D.; Tew, K. Oncogene 2003, 22, 7369-7375.